Binge eating

3 trials MedDRA PT
3 Registered trials
0 Recruiting
2 Unique sponsors
2 Unique IMPs
2 Commercial trials
Drug classes (ATC)
— ATC code not specified 2
H Endocrinology (ATC H) 1
Mechanism of action (INN-stem analysis)
Unknown / small molecule 1 substance
Corticosteroid 1 substance
Phase II: 2 Phase I (Other): 1

Filter these 3 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 3 trials

Phase II

2 trials
  • Bioprojet Pharma Commercial
    N-[4-[2-[4-(3-CYANOPHENYL)PIPERAZIN-1-YL]ETHYL]CYCLOHEXYL]-3-METHOXYPROPANAMIDE
    2023-506511-17-00 2 countries 2022 n=86
    Ended
  • Universitaetsmedizin Goettingen Academic
    HYDROCORTISONE
    2024-515475-35-00 1 country 2023 n=50
    Ended

Phase I (Other)

1 trial
  • Bioprojet Pharma Commercial
    IMP not specified
    2024-512355-20-00 1 country 2024 n=32
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Bioprojet Pharma Commercial 2 Phase I (Other), Phase II 0
Universitaetsmedizin Goettingen Academic 1 Phase II 0
New trials by year
2022
1
2023
1
2024
1
← All indication landscapes